Table 4.

Clinical outcomes at 12-month follow-up between DAPT and the only-aspirin groups

Items	DAPT (n = 42)	Only aspirin (n = 88)	χ2	P
Hemorrhage, n (%)	0 (0.0)	1 (1.1)	0.144	0.704
Death, n (%)	2 (4.8)	4 (4.5)	0.154	0.695
Endoleak, n (%)	0 (0.0)	3 (3.4)	0.344	0.558
Recurrent dissection, n (%)	0 (0.0)	3 (3.4)	0.344	0.558
Myocardial infarction, n (%)	1 (2.4)	0 (0.0)	0.144	0.704

DAPT: Dual-antiplatelet therapy.